2020
EYRIS SIGNS MOU WITH SINGAPORE OPTOMETRIST ASSOCIATION
Mar 2020 – Many amongst the general population are oblivious to the need for regular eye examination. To underscore this need, most of these eye conditions are silent and asymptomatic during early stages which can be vision threatening when it takes a turn for the worse. As professionals regulated by the Optometrist and Optician Board (OOB), optometrists are trained and…
AI to detect papilledema from ocular fundus photographs
April 2020 – Papilledema is optic disc swelling due to high intracranial pressure possibly due to many factors such as cerebral hemorrhage, head trauma, meningitis, hydrocephalus, spinal cord lesions, impairment of cerebral sinus drainage and idiopathic intracranial hypertension (IIH). Irrespective of the cause, visual loss is the feared morbidity of papilledema, and the main mechanism of optic nerve damage is…
EyRIS Founders Review Factors Influencing Performance of DLS
Mar 2020 – While the latest development in AI has been proven to be relatively accurate detecting retinal diseases, there has been little insight on what impacts clinical deployment in real-world settings. In a recent publication in NPJ Digital Medicine, EyRIS founders shared their findings from a systematic review of literature on possible factors, both image-related and technical affecting the…
NOVA SECURES NATIONWIDE PROJECT TO IMPLEMENT VESALIUS IN TONGA
Mar 2020 –The Ministry of Health, Kingdom of Tonga awarded VAMED, an international end-to-end provider of solutions to healthcare facilities – the project for management, implementation and support of the nationwide Health Information System (HIS) and Electronic Medical Record (EMR). Tonga has a population of about 107,000 people living on 170 islands spread across 750,000 square kilometers in the southern…
SELENA+ OBTAINS APPROVAL FOR MARKET ACCESS IN EU
9 Mar 2020 – EyRIS is pleased to announce that SELENA+, a deep learning AI system designed to detect diabetic retinopathy, glaucoma-suspect and age-related macular degeneration, jointly invented by clinicians and scientists from Singapore Eye Research Institute (SERI) and NUS School of Computing has received CE Marking certification. EyRIS is a start-up company established to commercialise SELENA+, which was trained…
SELENA+ HIGHLIGHTED AS PART OF NATIONAL STRATEGY TO DELIVER QUALITY CARE
5 Mar 2020 – In a debate on Singapore Health Ministry’s budget for the year, Minister Gan Kim Yong shared the plans to leverage technologies such as artificial Intelligence and robotics to deliver quality care in the nation’s ageing and growing population. One example highlighted by Minister Gan was SELENA+, a deep learning system (DLS) to check for diabetic retinopathy,…
EYRIS CO-FOUNDER DISCUSSES THE FUTURE OF AI IN OPHTHALMOLOGY
Jan 2020 – In the article published by the The Ophthalmologist – Ophthalmic Frontiers: AI, four recognized artificial intelligence and deep learning gurus discuss the use of these advanced technologies in eye care – and predict where they may take us next. We are pleased to share that Dr Daniel Ting, an EyRIS co-founder is one of the selected experts…
EYRIS CLEARS EN ISO13485:2016 AUDIT
Jan 2020 – EyRIS is pleased to announce that we have successfully undergone Phase 1 & 2 of EN ISO 13485:2016 audit by TÜV SÜD that was conducted across 2 days. The EN version required additional annexes to ensure compliance to quality management system clauses stated in the Medical Device Directive (MDD 93/42/EEC) Annex II. In addition, the product technical…
LAND TRANSPORT AUTHORITY, SINGAPORE AWARDS PROJECT TO NOVA FOR ERA SYSTEM UPGRADE
Jan 2020 –Singapore’s Land Transport Authority (LTA) has awarded to novaCITYNETS the project to upgrade and enhance the web-based Enterprise Registry and Archival (ERA) System. The ERA System became operational in March 2014 and since then system has been heavily utilised as the corporate-wide records and document management platform, with an aim to provide end-to-end management for all corporate resources…